Current issues in Tourette syndrome

Mov Disord. 2000 Nov;15(6):1051-63. doi: 10.1002/1531-8257(200011)15:6<1051::aid-mds1001>3.0.co;2-l.
No abstract available

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents / therapeutic use*
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Attention Deficit Disorder with Hyperactivity / epidemiology
  • Autoimmunity
  • Brain / immunology
  • Brain / metabolism
  • Brain / pathology*
  • Brain / physiopathology
  • Central Nervous System Stimulants / therapeutic use*
  • Comorbidity
  • Diagnosis, Differential
  • Genetic Predisposition to Disease
  • Humans
  • Neurotransmitter Agents* / agonists
  • Neurotransmitter Agents* / antagonists & inhibitors
  • Neurotransmitter Agents* / genetics
  • Neurotransmitter Agents* / metabolism
  • Obsessive-Compulsive Disorder / epidemiology
  • Prevalence
  • Severity of Illness Index
  • Tic Disorders / diagnosis
  • Tic Disorders / epidemiology*
  • Tourette Syndrome* / diagnosis
  • Tourette Syndrome* / drug therapy
  • Tourette Syndrome* / epidemiology
  • Tourette Syndrome* / metabolism

Substances

  • Antipsychotic Agents
  • Central Nervous System Stimulants
  • Neurotransmitter Agents